Alexandria Real Estate Equities Inc vs BioNTech SE - ADR — how do they compare? Alexandria Real Estate Equities Inc trades at $48.5 (market cap $8.28B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: BioNTech SE - ADR is far larger — about 2.8× Alexandria Real Estate Equities Inc's market cap, and Alexandria Real Estate Equities Inc pays a 5.99% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| ARE | BNTX | |
|---|---|---|
Market Cap | $8.28B | $23.31B |
Sector | Real Estate | Health |
52-Week High | $87.45 | $119.34 |
52-Week Low | $40.41 | $83.89 |
Enterprise Value | $20.98B | $6.60B |
Dividend Yield | 5.99% | — |
Trailing returns across standard periods
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.
Read more on ARE →BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →